Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development

Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers

(2013) Satoshi Imaizumi et al.   CURRENT PHARMACEUTICAL DESIGN

Dynamic CCAAT/Enhancer Binding Protein–Associated Changes of DNA Methylation in the Angiotensinogen Gene

(2013) Fen Wang et al.   HYPERTENSION

A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males

(2013) Xiaoling Wang et al.   PLoS One

DNA Hypomethylation, Ambient Particulate Matter, and Increased Blood Pressure: Findings From Controlled Human Exposure Experiments

(2013) Andrea Bellavia et al.   Journal of the American Heart Association

Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature

(2012) Aurelie Nguyen Dinh Cat et al.   ANTIOXIDANTS & REDOX SIGNALING

Tissue-Specific Upregulation of Angiotensin-Converting Enzyme 1 in Spontaneously Hypertensive Rats Through Histone Code Modifications

(2012) Hae-Ahm Lee et al.   HYPERTENSION

Reading the second genomic code

(2012) Vivien Marx   NATURE

Functions of DNA methylation: islands, start sites, gene bodies and beyond

(2012) Peter A. Jones   NATURE REVIEWS GENETICS

Expression of Na+-K+-2Cl− Cotransporter 1 Is Epigenetically Regulated During Postnatal Development of Hypertension

(2011) Hyun-Min Cho et al.   AMERICAN JOURNAL OF HYPERTENSION

Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension

(2011) Luminita H. Pojoga et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets

(2011) Sándor Bátkai et al.   CURRENT HYPERTENSION REPORTS

Cell Signaling of Angiotensin II on Vascular Tone: Novel Mechanisms

(2011) Aurelie Nguyen Dinh Cat et al.   CURRENT HYPERTENSION REPORTS

Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension

(2011) L Gabriel Navar et al.   CURRENT OPINION IN PHARMACOLOGY

Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches

(2011) T. Unger et al.   EUROPEAN HEART JOURNAL

Angiotensin II and the vascular phenotype in hypertension

(2011) Carmine Savoia et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

CpG islands and the regulation of transcription

(2011) A. M. Deaton et al.   GENES & DEVELOPMENT

Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart

(2011) Chun-Hsien Chu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Enrichment of (pro)renin receptor promoter with activating histone codes in the kidneys of spontaneously hypertensive rats

(2011) Hae-Ahm Lee et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy

(2010) Michael Bader   Annual Review of Pharmacology and Toxicology

Epigenetics and Hypertension

(2010) Richard M. Millis   CURRENT HYPERTENSION REPORTS

Angiotensin II receptors and drug discovery in cardiovascular disease

(2010) Chiranjib Dasgupta et al.   DRUG DISCOVERY TODAY

Conserved role of intragenic DNA methylation in regulating alternative promoters

(2010) Alika K. Maunakea et al.   NATURE

Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension

(2008) Simonetta Friso et al.   ATHEROSCLEROSIS

Molecular determinants of angiotensin II type 1 receptor functional selectivity

(2008) Mark Aplin et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY